Brain and Mind Centre

Camperdown, New South Wales 2050

0 studies enrolling now · 8 studies all time

What they study most

ALS, Amyotrophic Lateral Sclerosis, Autism Spectrum Disorder, Motor Neuron Disease, Multiple Sclerosis, Relapsing-Remitting

Studies at this site

• ML-004 Open-Label Extension Study in Adults and Adolescents With Autism Spectrum Disorders (ASD) — Running, not enrolling
• ML-004 in Adolescents and Adults With Autism Spectrum Disorders (ASD) — Completed
• MERIDIAN: A Study to Evaluate the Efficacy and Safety of Pegcetacoplan in Adults With Amyotrophic Lateral Sclerosis (ALS) — Stopped early
• Study to Evaluate the Effectiveness and Safety of Ocrelizumab in Participants With Early Stage Relapsing Remitting Multiple Sclerosis (RRMS) — Stopped early
• A Study to Evaluate the Efficacy and Safety of Reldesemtiv in Patients With Amyotrophic Lateral Sclerosis (ALS) — Stopped early
• Effects of Oral Levosimendan on Respiratory Function in Patients With Amyotrophic Lateral Sclerosis (ALS): Open-Label Extension — Stopped early
• An Efficacy and Safety Study of Ravulizumab in ALS Participants — Stopped early
• Effects of Oral Levosimendan (ODM-109) on Respiratory Function in Patients With ALS — Completed